Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Clinical trial NCT05079360 · WITHDRAWN
Trial details
- NCT number
- NCT05079360
- Sponsor
- Veru Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2024-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.